Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from PFE

Thursday's Unusual Options Activity Reveals 3 Promising Long-Term Investments

Thursday's trading session revealed 33 call options with unusually high activity and boasting expiration dates of 365 days or more. Three have emerged as promising long-term investments from this diverse pool of potential opportunities.

Barchart

3 Defensive Stocks to Buy as Market Volatility Rises

Amid current economic uncertainties and market volatility, investing in defensive stocks appears as an ideal strategy for portfolio protection. Thus, quality defensive stocks Johnson & Johnson (JNJ), Pfizer (PFE), and Genie Energy (GNE) could be ideal portfolio additions as market volatility rises. Continue reading.

StockNews.com

3 Healthcare Stocks for Long-Term Stability and Growth

With the rise of chronic diseases, technological advances and innovative drug pipelines are driving significant growth in the healthcare industry. Hence, investors may find long-term stability and exciting opportunities by adding stocks, Johnson & Johnson (JNJ), Pfizer (PFE), and Cigna Group (CI), to their portfolios. Read more….

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Is This High-Yield Dividend Stock a Buy After Earnings?

This pharmaceutical giant's Q3 numbers came in ahead of Street estimates.

Barchart

3 High-Yield Dividend Stocks to Buy for Steady Passive Income

In times of market uncertainties, high-dividend yield stocks are ideal investment choices for their qualities like stable passive income, protection against inflation, and price appreciation. Thus, investors could consider fundamentally sound, high dividend yield stocks Verizon Communications (VZ), Pfizer (PFE), and Enterprise Products Partners (EPD) for steady passive income. Read…

StockNews.com

Are Wall Street Analysts Predicting Pfizer Stock Will Climb or Sink?

Despite Pfizer’s underperformance relative to the broader market over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

What to Expect From Pfizer's Q3 2024 Earnings Report

Pfizer is expected to release its fiscal third-quarter earnings later this month, and analysts project a triple-digit profit growth.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Should You Follow Activist Investors Into This High-Yield Dividend Stock?

This dividend stock is now on the radar of activist investors, with Starboard eyeing a possible management shakeup.

Barchart

Stock Market Today: Markets Slip on Hot Inflation Print, Layoff News

Economic data continues to complicate expectations for Federal Reserve rate cuts.

Kiplinger

Is This Overlooked Dividend Stock Yielding Almost 6% a Good Turnaround Play?

Despite its dividend yield of nearly 6%, Pfizer stock has failed to win over investors and is in the red YTD. Can the stock finally stage a turnaround, as activist investor Starboard Value has reportedly taken a stake in the company?

Barchart

2 Covered Call Ideas on Pfizer Stock

Today, we’re looking at two covered call examples on Pfizer stock. The first step to finding our covered call candidates is to use the Stock Scanner with the following parameters:

Barchart

How to Buy PFE For a 6% Discount, or Achieve a 23% Annual Return

Selling cash secured puts on stocks an investor is happy to take ownership of is a great way to generate some extra income.

Barchart

3 High-Dividend Pharma Blue Chips That Are on Sale Right Now

With the Federal Reserve potentially cutting interest rates for the first time in over four years, uncertainty looms in the market. Amid this backdrop, it could be wise to scoop up the shares of fundamentally sound pharma stocks like AbbVie (ABBV), Novartis (NVS), and Pfizer (PFE), which are not just…

StockNews.com

3 Healthcare Stocks With High Analyst Price Targets

Recent innovations, successful trials, and increased research and development spending in the healthcare sector further boost the sector’s appeal today. Given this momentum, investors might consider investing in stocks with high analyst price targets, such as Pfizer (PFE), Biogen (BIIB), and BioMarin Pharmaceutical (BMRN). Read on….

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

3 Undervalued Healthcare Stocks With Strong Upside Potential

The healthcare sector is set for robust growth, driven by surging demand for quality treatments, a growing patient base, breakthroughs in biopharma, and supportive policies. Therefore, investors could consider undervalued pharmaceutical stocks like Merck & Co. (MRK), Pfizer (PFE), and Cigna (CI) with significant upside potential. Read more.

Barchart

Is Pfizer Stock Underperforming the Dow?

Although Pfizer underperformed the Dow Jones this year, analysts are moderately bullish on the stock’s prospects.

StockNews.com

3 Stocks Benefiting From the Aging Population

As the aging population drives significant opportunities for companies involved in pharmaceuticals, medical devices, and health care services, let’s not miss out on investing in quality stocks like Thermo Fisher Scientific (TMO), Medtronic (MDT), and Korn Ferry (KFY), which are poised to meet the needs of an aging demographic. Learn…

Barchart

3 High-Yield S&P 500 Stocks to Buy and Hold

Three high-yield S&P 500 stocks, Devon Energy, Verizon Communications, and Pfizer Inc., are poised to provide a balanced mix of income and growth, making them attractive options for long-term investors.

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

3 Healthcare Stocks Positioned for Major Gains in 2024

With advancements in biomedical sciences and promising drug pipelines, the healthcare industry is set for substantial growth in the coming years. Hence, investors might find opportunities in adding UnitedHealth Group (UNH), Merck & Co. (MRK), and Pfizer (PFE) to their portfolios for potential gains this year. Read on….

StockNews.com

3 Must-Buy Healthcare Stocks for Defensive Investing

The healthcare sector is set for significant growth due to advancements in pharma technology, increasing demand for personalized medicines, and resilience even in economic downturns. Therefore, investors might consider buying quality pharmaceutical stocks like Pfizer (PFE), Johnson & Johnson (JNJ), and AbbVie (ABBV) for defensive investing. Read on.

Barchart

2 Dividend Stocks to Buy in August If the Market Crash Scares You

Volatility is back on Wall Street, which is bound to scare some investors. Meanwhile, Pfizer and Starbucks are two high dividend names with limited downside which conservative investors can consider now.

Barchart

Is Wall Street Bullish or Bearish on Pfizer Stock?

Pfizer has underperformed relative to the broader market over the past year, yet Wall Street analysts remain moderately bullish about the stock’s outlook.

Kiplinger

Pfizer Stock Slips After Beat-And-Raise Quarter: What to Know

Pfizer reported a notable year-over-year decline in Q2 earnings, but the results still beat expectations. Here's what investors should know.

Barchart

1 High-Yield Dividend Stock to Buy and Hold

Pfizer's stock shows signs of a potential rebound, buoyed by recent pipeline successes in hemophilia and obesity treatments, an attractive 5% dividend yield, and a rock-bottom valuation. This makes it an appealing dividend stock for value and income investors as the drug giant prepares to report earnings.

Barchart

Here's What to Expect From Pfizer’s Next Earnings Report

As Pfizer gears up to release its second-quarter earnings this month, analysts project a double-digit bottom-line dip.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.